Document Detail

More than satiety: central serotonin signaling and glucose homeostasis.
MedLine Citation:
PMID:  17983579     Owner:  NLM     Status:  MEDLINE    
Serotonergic agents have been used in the past for reduction of appetite and body weight. As reported by Zhou et al. (2007) in this issue of Cell Metabolism, they also have unexpected effects on peripheral glucose homeostasis independent of food intake and body weight.
Pavlos Pissios; Eleftheria Maratos-Flier
Related Documents :
18484299 - Dietary exposure assessment of danish consumers to dithiocarbamate residues in food: a ...
9306309 - Effects of immobilization restraint on syrian golden hamsters.
459039 - Wet versus dry weights for heavy metal toxicity determinations in duck liver.
18257959 - The effects of antipsychotics on the density of cannabinoid receptors in the dorsal vag...
18848969 - Acute, subchronic and genotoxicity studies conducted with oligonol, an oligomerized pol...
16039759 - Effects of physical activity on food intake.
29799 - Estrogens in food: the almond mystery.
17410789 - Noble gas excess air applied to distinguish groundwater recharge conditions.
11600079 - Precise tuning of barnacle leg length to coastal wave action.
Publication Detail:
Type:  Comment; Journal Article    
Journal Detail:
Title:  Cell metabolism     Volume:  6     ISSN:  1550-4131     ISO Abbreviation:  Cell Metab.     Publication Date:  2007 Nov 
Date Detail:
Created Date:  2007-11-06     Completed Date:  2008-02-26     Revised Date:  2014-09-14    
Medline Journal Info:
Nlm Unique ID:  101233170     Medline TA:  Cell Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  345-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Glucose / metabolism*
Homeostasis / drug effects*
Models, Biological
Serotonin 5-HT2 Receptor Agonists
Serotonin Receptor Agonists / pharmacology*
Signal Transduction / drug effects
Grant Support
P01 DK056116/DK/NIDDK NIH HHS; P01 DK056116-010002/DK/NIDDK NIH HHS; P01 DK056116-020002/DK/NIDDK NIH HHS; P01 DK056116-030002/DK/NIDDK NIH HHS; P01 DK056116-040002/DK/NIDDK NIH HHS; P01 DK056116-050002/DK/NIDDK NIH HHS; P01 DK056116-06A10002/DK/NIDDK NIH HHS; P01 DK056116-06A19002/DK/NIDDK NIH HHS; P01 DK056116-070002/DK/NIDDK NIH HHS; P01 DK056116-079002/DK/NIDDK NIH HHS; P01 DK056116-080002/DK/NIDDK NIH HHS; P01 DK056116-089002/DK/NIDDK NIH HHS; P01 DK056116-090002/DK/NIDDK NIH HHS; P01 DK056116-099002/DK/NIDDK NIH HHS; R01 DK056113/DK/NIDDK NIH HHS; R01 DK056113-05/DK/NIDDK NIH HHS; R01 DK069983/DK/NIDDK NIH HHS; R01 DK069983-01A1/DK/NIDDK NIH HHS; R01 DK069983-02/DK/NIDDK NIH HHS; R01 DK069983-03/DK/NIDDK NIH HHS
Reg. No./Substance:
0/Serotonin 5-HT2 Receptor Agonists; 0/Serotonin Receptor Agonists; IY9XDZ35W2/Glucose
Comment On:
Cell Metab. 2007 Nov;6(5):398-405   [PMID:  17983585 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  DisSIRTing on LXR and cholesterol metabolism.
Next Document:  Metabolomics.